can't afford glp 1 Connecticut is moving to eliminate Medicaid coverage of GLP-1 weight loss drugs like Ozempic and Mounjaro, a decision that could leave thousands of residents without access to medications that have transformed obesity Ozempic/Mounjaro Too Expensive? How to

Blood donation organizations consistently need volunteer support beyond the donation chair, and your contribution can be equally valuable during this period

These changes are most pronounced in people who lose weight rapidly or who started treatment at a higher body weight

The subcutaneous injection cycle followed by oral NMN maintenance is the approach our clinic uses to sustain those improvements between active treatment phases

Looking to the Future Despite the estimated 20% prevalence of MCAS in the general population, there are currently no MCAS-focused clinical trials for GLP-1 receptor agonists

The mechanics of your food plan depend on these details